|
Article Cited by others ORIGINAL ARTICLE
Ivermectin as an adjunct treatment for hospitalized adult COVID-19 patients: A randomized multi-center clinical trial
Shakhsi Niaee Morteza, Namdar Peyman, Allami Abbas, Zolghadr Leila, Javadi Amir, Karampour Amin, Varnaseri Mehran, Bijani Behzad, Cheraghi Fatemeh, Naderi Yazdan, Amini Fatemeh, Karamyan Masoumeh, YadYad Mohammad Jafar, Jamshidian Ramin, Gheibi Nematollah
Year : 2021| Volume: 14| Issue : 6 | Page no: 266-273 | This article has been cited by | | 1 |
Ivermectin for COVID-19: Addressing Potential Bias and Medical Fraud |
|
| | Andrew Hill, Manya Mirchandani, Victoria Pilkington | | | Open Forum Infectious Diseases. 2022; 9(2) | | | [Pubmed] [Google Scholar] [DOI] | | | 2 |
Meta-Analyses Do Not Establish Improved Mortality With Ivermectin Use in COVID-19 |
|
| | Steven G. Rothrock, Kurt D. Weber, Philip A. Giordano, Mitchell D. Barneck | | | American Journal of Therapeutics. 2022; 29(1): e87 | | | [Pubmed] [Google Scholar] [DOI] | | | 3 |
Re: “Commentary” by Rothrock et al. “Meta-Analyses Did Not Establish Improved Mortality With Ivermectin Use in COVID-19” |
|
| | Andrew Bryant, Theresa A. Lawrie, Edmund J. Fordham, Scott Mitchell | | | American Journal of Therapeutics. 2022; 29(2): e233 | | | [Pubmed] [Google Scholar] [DOI] | | | 4 |
Meta-Analyses Do Not Establish Improved Mortality With Ivermectin Use in COVID-19 |
|
| | Steven G. Rothrock, Kurt D. Weber, Philip A. Giordano, Mitchell D. Barneck | | | American Journal of Therapeutics. 2022; 29(2): e237 | | | [Pubmed] [Google Scholar] [DOI] | | | 5 |
Dose-Dependent Ivermectin Effect on COVID-19 Polymerase Chain Reaction Status |
|
| | Nirmeen Sabry, Yasser Fouad, Mohamed AbdAllah, Ahmed Cordie, Gamal Esmat | | | American Journal of Therapeutics. 2022; Publish Ah | | | [Pubmed] [Google Scholar] [DOI] | | | 6 |
Identification and Development of Therapeutics for COVID-19 |
|
| | Halie M. Rando, Nils Wellhausen, Soumita Ghosh, Alexandra J. Lee, Anna Ada Dattoli, Fengling Hu, James Brian Byrd, Diane N. Rafizadeh, Ronan Lordan, Yanjun Qi, Yuchen Sun, Christian Brueffer, Jeffrey M. Field, Marouen Ben Guebila, Nafisa M. Jadavji, Ashwin N. Skelly, Bharath Ramsundar, Jinhui Wang, Rishi Raj Goel, YoSon Park, Simina M. Boca, Anthony Gitter, Casey S. Greene, Jack A. Gilbert | | | mSystems. 2021; | | | [Pubmed] [Google Scholar] [DOI] | | | 7 |
Efficacy of COVID-19 Treatments: A Bayesian Network Meta-Analysis of Randomized Controlled Trials |
|
| | Chenyang Zhang,Huaqing Jin,Yi Feng Wen,Guosheng Yin | | | Frontiers in Public Health. 2021; 9 | | | [Pubmed] [Google Scholar] [DOI] | | | 8 |
Bayesian Hypothesis Testing and Hierarchical Modeling of Ivermectin Effectiveness |
|
| | Martin Neil,Norman Fenton | | | American Journal of Therapeutics. 2021; 28(5): e576 | | | [Pubmed] [Google Scholar] [DOI] | | | 9 |
The lesson of ivermectin: meta-analyses based on summary data alone are inherently unreliable |
|
| | Jack M. Lawrence,Gideon Meyerowitz-Katz,James A. J. Heathers,Nicholas J. L. Brown,Kyle A. Sheldrick | | | Nature Medicine. 2021; | | | [Pubmed] [Google Scholar] [DOI] | | | 10 |
Comparative effectiveness of pharmacological interventions on mortality and the average length of hospital stay of patients with COVID-19: a systematic review and meta-analysis of randomized controlled trials |
|
| | Abolfazl Akbari, Mahya Razmi, Alireza Sedaghat, Seyyed Mohammad Matin Alavi Dana, Mahdi Amiri, Ali Mohammad Halvani, Soroush Yazdani, Sajad Sahab-Negah | | | Expert Review of Anti-infective Therapy. 2021; | | | [Pubmed] [Google Scholar] [DOI] | |
|
|
|
|
